Bruker (NASDAQ:BRKR) declared a quarterly dividend on Tuesday, May 15th, Wall Street Journal reports. Stockholders of record on Monday, June 4th will be paid a dividend of 0.04 per share by the medical research company on Friday, June 22nd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend is Friday, June 1st.
Shares of NASDAQ BRKR opened at $30.38 on Friday. Bruker has a twelve month low of $26.76 and a twelve month high of $36.53. The company has a market capitalization of $4.74 billion, a PE ratio of 23.92, a price-to-earnings-growth ratio of 2.00 and a beta of 1.14. The company has a current ratio of 2.22, a quick ratio of 1.29 and a debt-to-equity ratio of 0.26.
Bruker (NASDAQ:BRKR) last announced its earnings results on Thursday, May 3rd. The medical research company reported $0.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.02. Bruker had a return on equity of 27.04% and a net margin of 4.63%. The firm had revenue of $431.70 million for the quarter, compared to the consensus estimate of $419.25 million. During the same quarter in the previous year, the business earned $0.19 EPS. The company’s revenue was up 12.2% compared to the same quarter last year. analysts forecast that Bruker will post 1.39 EPS for the current fiscal year.
A number of brokerages have recently weighed in on BRKR. BidaskClub upgraded Bruker from a “hold” rating to a “buy” rating in a research note on Wednesday. Zacks Investment Research upgraded Bruker from a “hold” rating to a “buy” rating and set a $34.00 target price on the stock in a research note on Tuesday, May 8th. BTIG Research set a $42.00 target price on Bruker and gave the stock a “buy” rating in a research note on Sunday, May 6th. Bank of America cut their target price on Bruker from $37.00 to $34.00 and set a “neutral” rating on the stock in a research note on Friday, May 4th. Finally, Morgan Stanley cut their target price on Bruker from $35.00 to $32.00 and set an “equal weight” rating on the stock in a research note on Friday, February 9th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $32.91.
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.